Mediation of Increased Vascular Permeability After Complement Activation. Histamine-independent Action of Rabbit C5a

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1981 Jan 1

PMID 6161204

Citations 52

Authors

T J Williams

P J Jose

Affiliations

Soon will be listed here.

Abstract

Intradermal injection of zymosan into nonsensitized rabbits induces plasma exudation, which is dependent on two mediators: C5a generated in extravascular tissue fluid and a vasodilator prostaglandin generated from substrates localized in cell membranes. This relationship between the complement system and the prostaglandin synthesis system had not previously been explored, and complement activation has generally been associated with increased vascular permeability via histamine release. We report that C5a increases vascular permeability by a mechanism that is not dependent on histamine release; however plasma exudation is virtually undetectable in the absence of a vasodilator substance. Because the permeability-increasing activity is stable in plasma, analogy with other species suggests that the activity is a result of C5a devoid of its carboxyl terminal arginine (C5a des Arg). This relates the observed permeability-increasing activity with effects on leukocytes rather than effects as an anaphylatoxin.

Citing Articles

C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease.

Kristin Henes J, Groga-Bada P, Schaeffeler E, Winter S, Hack L, Zdanyte M Pharmgenomics Pers Med. 2021; 14:893-903.

PMID: 34321906 PMC: 8312322. DOI: 10.2147/PGPM.S307827.

Blood-derived plasminogen drives brain inflammation and plaque deposition in a mouse model of Alzheimer's disease.

Baker S, Chen Z, Norris E, Revenko A, MacLeod A, Strickland S Proc Natl Acad Sci U S A. 2018; 115(41):E9687-E9696.

PMID: 30254165 PMC: 6187132. DOI: 10.1073/pnas.1811172115.

Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population.

Benasutti H, Wang G, Vu V, Scheinman R, Groman E, Saba L Bioconjug Chem. 2017; 28(11):2747-2755.

PMID: 29090582 PMC: 6231230. DOI: 10.1021/acs.bioconjchem.7b00496.

Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.

Inturi S, Wang G, Chen F, Banda N, Holers V, Wu L ACS Nano. 2015; 9(11):10758-68.

PMID: 26488074 PMC: 5224875. DOI: 10.1021/acsnano.5b05061.

Neutrophils recruited by chemoattractants in vivo induce microvascular plasma protein leakage through secretion of TNF.

Finsterbusch M, Voisin M, Beyrau M, Williams T, Nourshargh S J Exp Med. 2014; 211(7):1307-14.

PMID: 24913232 PMC: 4076577. DOI: 10.1084/jem.20132413.

References

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Fernandez H, Henson P, Otani A, Hugli T . Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol. 1978; 120(1):109-15. View

VOGT W . Preparation and some properties of anaphylatoxin from hog serum. Biochem Pharmacol. 1968; 17(5):727-33. DOI: 10.1016/0006-2952(68)90009-9. View

Snyderman R, Phillips J, Mergenhagen S . Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun. 1970; 1(6):521-5. PMC: 415936. DOI: 10.1128/iai.1.6.521-525.1970. View

Heideman M, Kaijser B, Gelin L . Complement activation and hematologic, hemodynamic, and respiratory reactions early after soft-tissue injury. J Trauma. 1978; 18(10):696-700. DOI: 10.1097/00005373-197810000-00002. View

Williams T, Morley J . Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature. 1973; 246(5430):215-7. DOI: 10.1038/246215a0. View

Cochrane C, MULLER-EBERHARD H . The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med. 1968; 127(2):371-86. PMC: 2138443. DOI: 10.1084/jem.127.2.371. View

UNANUE E . Secretory function of mononuclear phagocytes: a review. Am J Pathol. 1976; 83(2):396-418. PMC: 2032318. View

Dias da Silva W, Lepow I . Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J Exp Med. 1967; 125(5):921-46. PMC: 2138204. DOI: 10.1084/jem.125.5.921. View

10.

Bodammer G, VOGT W . [Effect of anaphylatoxin (AT) upon capillary permeability in guinea pig skin]. Naunyn Schmiedebergs Arch Pharmakol. 1970; 266(3):255-60. View

11.

Andrews P . Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochem J. 1964; 91(2):222-33. PMC: 1202876. DOI: 10.1042/bj0910222. View

12.

Henson P, McCarthy K, Larsen G, Webster R, Giclas P, Dreisin R . Complement fragments, alveolar macrophages, and alveolitis. Am J Pathol. 1979; 97(1):93-110. PMC: 2042383. View

13.

Bokisch V, MULLER-EBERHARD H . Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest. 1970; 49(12):2427-36. PMC: 322744. DOI: 10.1172/JCI106462. View

14.

Williams T, Peck M . Role of prostaglandin-mediated vasodilatation in inflammation. Nature. 1977; 270(5637):530-2. DOI: 10.1038/270530a0. View

15.

Burke J, MILES A . The sequence of vascular events in early infective inflammation. J Pathol Bacteriol. 1958; 76(1):1-19. View

16.

Fernandez H, Hugli T . Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Biol Chem. 1978; 253(19):6955-64. View

17.

MILES A, MILES E, Burke J . The value and duration of defence reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol. 1957; 38(1):79-96. PMC: 2082171. View

18.

Ford-Hutchinson A, Bray M, Doig M, Shipley M, Smith M . Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980; 286(5770):264-5. DOI: 10.1038/286264a0. View

19.

OSLER A, HAWRISIAK M, OVARY Z, Siqueira M, Bier O . Studies on the mechanism of hypersensitivity phenomena. II. The participation of complement in passive cutaneous anaphylaxis of the albino rat. J Exp Med. 1957; 106(6):811-34. PMC: 2136829. DOI: 10.1084/jem.106.6.811. View

20.

Hugli T, MULLER-EBERHARD H . Anaphylatoxins: C3a and C5a. Adv Immunol. 1978; 26:1-53. DOI: 10.1016/s0065-2776(08)60228-x. View